Detalhe da pesquisa
1.
The growing threat of NDM-producing E. coli with penicillin-binding protein 3 mutations in the United States - is there a potential role for durlobactam?
Clin Infect Dis
; 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38661186
2.
An Open-Label, Randomized Trial Comparing Fidaxomicin With Oral Vancomycin for the Treatment of Clostridioides difficile Infection in Hospitalized Patients Receiving Concomitant Antibiotics for Concurrent Infections.
Clin Infect Dis
; 78(2): 277-282, 2024 02 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37797310
3.
Population pharmacokinetic/pharmacodynamic target attainment analysis of IV fosfomycin for the treatment of MDR Gram-negative bacterial infections.
J Antimicrob Chemother
; 2024 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38597137
4.
A comparison of strategies for identifying patients at risk for carbapenem-resistant or extended ß-lactam-resistant Pseudomonas aeruginosa.
J Antimicrob Chemother
; 2024 Apr 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38581308
5.
Less Is More? Antibiotic Treatment Duration in Pseudomonas aeruginosa Ventilator-Associated Pneumonia.
Clin Infect Dis
; 76(4): 745-749, 2023 02 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36130230
6.
State of the Management of Infections Caused by Multidrug-Resistant Gram-Negative Organisms.
Clin Infect Dis
; 77(9): e46-e56, 2023 11 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37738671
7.
Case Commentary: When Voldemort Meets Sauron: Treatment Considerations for Emerging Dual-Carbapenemase-Producing Extensively Drug-Resistant Pseudomonas aeruginosa.
Antimicrob Agents Chemother
; 67(7): e0047523, 2023 07 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37310216
8.
Burden of illness in carbapenem-resistant Acinetobacter baumannii infections in US hospitals between 2014 and 2019.
BMC Infect Dis
; 22(1): 36, 2022 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34991499
9.
Antibiotic Overuse After Hospital Discharge: A Multi-hospital Cohort Study.
Clin Infect Dis
; 73(11): e4499-e4506, 2021 12 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32918077
10.
Tocilizumab for Treatment of Mechanically Ventilated Patients With COVID-19.
Clin Infect Dis
; 73(2): e445-e454, 2021 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32651997
11.
Clinical Implications of Microbiologic Treatment Failure in the Setting of Clinical Cure of Bacterial Pneumonia.
Clin Infect Dis
; 71(12): 3033-3041, 2020 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31832641
12.
Ceftolozane/Tazobactam vs Polymyxin or Aminoglycoside-based Regimens for the Treatment of Drug-resistant Pseudomonas aeruginosa.
Clin Infect Dis
; 71(2): 304-310, 2020 07 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31545346
13.
Polymyxin Susceptibility Testing and Interpretive Breakpoints: Recommendations from the United States Committee on Antimicrobial Susceptibility Testing (USCAST).
Antimicrob Agents Chemother
; 64(2)2020 01 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-31767718
14.
Ceftazidime/Avibactam, Meropenem/Vaborbactam, or Both? Clinical and Formulary Considerations.
Clin Infect Dis
; 68(3): 519-524, 2019 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30020449
15.
Analysis of Pooled Phase III Efficacy Data for Delafloxacin in Acute Bacterial Skin and Skin Structure Infections.
Clin Infect Dis
; 68(Suppl 3): S223-S232, 2019 04 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30957167
16.
The Hypothetical Impact of Accelerate Pheno on Time to Effective Therapy and Time to Definitive Therapy for Bloodstream Infections Due to Drug-Resistant Gram-Negative Bacilli.
Antimicrob Agents Chemother
; 63(3)2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30559141
17.
The hypothetical impact of Accelerate Pheno™ system on time to effective therapy and time to definitive therapy in an institution with an established antimicrobial stewardship programme currently utilizing rapid genotypic organism/resistance marker identification.
J Antimicrob Chemother
; 74(Suppl 1): i32-i39, 2019 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30690538
18.
Toxicity in Patients.
Adv Exp Med Biol
; 1145: 289-304, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31364083
19.
Executive Summary: State-of-the-Art Review: State of the Management of Infections Caused by Multidrug-Resistant Gram-Negative Organisms.
Clin Infect Dis
; 77(9): 1223-1225, 2023 11 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37952120
20.
An Antibiotic Stewardship Program Blueprint for Optimizing Verigene BC-GN within an Institution: a Tale of Two Cities.
Antimicrob Agents Chemother
; 62(5)2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29483115